JEWELIA GAHAN: Open Payments
NPI 1154979177 · TRUSSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$611 in 37 payments from 11 companies in 2025. Trend: 2023 $457 · 2024 $571 · 2025 $611
Food & beverage: $611
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $140 |
| Novo Nordisk Inc | 6 | $113 |
| Exact Sciences Corporation | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 3 | $72 |
| Astellas Pharma US Inc | 2 | $55 |
| Acella Pharmaceuticals, LLC | 2 | $35 |
| PFIZER INC. | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| IBSA Pharma Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
Products named: UBRELVY, Cologuard Collection Kit, Veozah, QULIPTA, FARXIGA, NP Thyroid 60, Symbravo, BREZTRI.
Industry payments across AL — which companies pay providers there.
